Biotech

All Articles

BioAge eyes $180M coming from IPO, exclusive positioning for excessive weight trials

.BioAge Labs is considering around $180 million in first proceeds coming from an IPO as well as a pr...

Merck's LAG-3 combination stops working colorectal cancer cells phase 3 study

.An effort through Merck &amp Co. to uncover the microsatellite dependable (MSS) metastatic colorect...

Spanish VC finalizes $200M lifestyle scientific researches fund

.Spain-based Asabys Allies has shut a fund of 180 thousand europeans ($ 200 million), amount of mone...

BioAge brings in $198M from IPO as excessive weight biotech joins Nasdaq

.BioAge Labs is actually introducing almost $200 million through its own Nasdaq IPO this morning, wi...

Acadia takes BMS vet on board as CEO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...

Cassava pays $40M over apparently misleading Alzheimer's improve

.Cassava Sciences has actually consented to pay for $40 million to deal with an examination in to in...

Merck bags possibilities on Evaxion's AI-designed vaccination applicants

.Merck &amp Co. has actually grabbed options on pair of Evaxion Biotech injection candidates, paying...

Enanta's RSV antiviral crushes virus-like lots in difficulty research

.Enanta Pharmaceuticals has actually linked its respiratory system syncytial infection (RSV) antivir...

Biogen containers SAGE-324 collaboration after crucial trembling neglect

.Biogen has actually carried out the last ceremonies to its partnership along with Sage Rehabs on SA...

AbbVie Parkinson's drug from $8.7 B Cerevel buyout ratings

.On the same day that some Parkinson's illness medications are being actually cast doubt on, AbbVie ...